Skip to main content

Year: 2019

Virbac : mise à disposition de l’information financière trimestrielle au 30 septembre 2019

Virbac : mise à disposition de l’information financière trimestrielle au 30 septembre 2019Communiqué diffusé le 15 novembre 2019L’information financière trimestrielle au 30 septembre 2019 est disponible :• sur notre site internet : corporate.virbac.com dans l’espace Investisseurs – Rapports financiers – 2019 ;• ou sur simple demande, dans les conditions légales et réglementaires.Conformément aux dispositions édictées par l’Autorité des marchés financiers (AMF), ce document présente:• les opérations et évènements significatifs de la période ;• une description de la situation financière et des résultats du groupe ;• la répartition du chiffre d’affaires par secteur d’activité.Virbac : NYSE Euronext – compartiment A – code ISIN : FR0000031577 / MNEMO : VIRPDirection financière : tél. 04 92 08 71 32 – finances@virbac.com...

Continue reading

Ambarella to Present at the Deutsche Bank 2019 Auto Tech Conference December 10, 2019

SANTA CLARA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) — Ambarella, Inc., (NASDAQ: AMBA), a leading developer of low-power and high-resolution human and computer vision solutions, today announced Fermi Wang, CEO, will be presenting at the Deutsche Bank 2019 Auto Tech Conference at the Fairmont Hotel in San Francisco, on Tuesday, December 10, 2019.The “fireside chat” presentation is scheduled for 9:30 AM PST and will be webcast on the Investor events page of Ambarella’s website at http://investor.ambarella.com/events.cfm.  A replay will be available on the website for 90 days.About AmbarellaAmbarella’s products are used in a wide variety of human and computer vision applications, including  video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and other robotic...

Continue reading

CarGurus Releases Second Annual Electric Vehicle Survey

CAMBRIDGE, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) — CarGurus (Nasdaq: CARG) a leading automotive marketplace, today released the results of its second annual CarGurus Electric Vehicle Survey. This year’s survey shows an upswing in consumers’ interest in purchasing electric vehicles (EVs), with 45% saying they will probably own an EV in the next ten years, up from 34% compared to last year. Even more significant, 26% of consumers said they intend to purchase an EV in the next five years, nearly double the number reported in 2018 (15%).Despite the growing interest in EVs, consumers still cite concerns that the cost and infrastructure are posing as barriers to purchase. Sixty-seven percent of consumers said cost was a primary issue in purchasing an EV, and 56% of consumers said lack of charging stations was a concern; echoing last year’s...

Continue reading

Gevo Appoints Lynn Smull as Chief Financial Officer

ENGLEWOOD, Colo, Nov. 15, 2019 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), a leading renewable fuels and chemicals manufacturer, announced today the appointment of Lynn Smull to the position of Chief Financial Officer.Mr. Smull is expected to start in this new role effective December 16, 2019.“I’m glad to have Lynn join our team. He has a lot of experience in project financing and energy projects, both extremely relevant to us” said Dr. Patrick R. Gruber, Gevo’s Chief Executive Officer. “Lynn is a good fit and I expect him to hit the ground running.”About GevoGevo is commercializing the next generation of gasoline, jet fuel and diesel fuel with the potential to achieve zero carbon emissions, addressing the market need of reducing greenhouse gas emissions with sustainable alternatives. Gevo uses low-carbon renewable resource-based...

Continue reading

Anchiano Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a biopharmaceutical company focused on discovery and development of novel therapies to treat cancer, today reported financial results for its third quarter and nine months ended September 30, 2019.Key Developments and Recent HighlightsAnnounced the discontinuation of its Phase 2 Codex study evaluating the gene therapy inodiftagene vixteplasmid in patients with BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC). After a thorough analysis of the data, Anchiano determined that there is a low probability of surpassing the pre-defined futility threshold at the planned interim analysis, which required 10 complete responses in 35 patients. The data also indicate a low probability of achieving an efficacy profile that in Anchiano’s...

Continue reading

BioLargo Reports Solid Operating Results in Third Quarter as it Breaks Revenue Records

Revenue grew 93% compared with third quarter 2018Revenue grew 53% compared with nine-months 2018Quarter over quarter revenues averaging a 25% increase for the past 3 yearsNew PFAS solution confirms efficacyWestminster, CA, Nov. 15, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioLargo, Inc. (OTCQB:BLGO) (“the Company”), developer of sustainable products and a full-service environmental engineering company, today announced the filing of its 10-Q quarterly report for the third quarter of 2019. Company management encourages its stockholders to review the quarterly report at www.biolargo.com/sec-filings. Highlights from the Quarterly Report:  Combined revenues from BioLargo’s operating units during the third quarter of 2019 grew 93% over the third quarter of 2018 to $534,000. Combined revenues from BioLargo’s operating units during...

Continue reading

Veritas Farms Reports Record 165% Increase in Q3 2019 Revenue from Q3 2018, as a Result of Expanding Brick-and-Mortar and Online Distribution Networks

Fort Lauderdale, FL, Nov. 15, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB: VFRM), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, today announced that the Company has reported its operating results for the three and nine months ended September 30, 2019, through the filing of its Quarterly Report on Form 10-Q with the Securities and Exchange Commission.  Selected Financial Highlights – 3rd Quarter Ended September 30, 2019 Total Revenues: Up 165% to $1,215,810 compared to $459,329 in Q3 2018 Total Revenue: Up 347% to $5,712,085 compared to $1,277,914 Year-To-Date 2018 Gross Profit: Up 468% to $495,058, compared to $87,187 in Q3 2018 Gross Profit: Up 578% to $2,645,905, compared to $390,074 Year-To-Date 2018 Total...

Continue reading

OLB Group, Inc. Announces Third Quarter Results and Provides Company Update

NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) — The OLB Group, Inc. (“OLBG,” “we,” “us,” “our,” or the “Company”), a FinTech company, has announced financial results for the third quarter ended September 30, 2019.We are a FinTech company and a payment facilitator that, through our subsidiaries, focuses on a suite of products in the merchant services and payment facilitator verticals. These services include electronic payment processing, cloud-based multi-channel commerce platform solutions for small to medium sized businesses and crowd funding services. The Company is focused on providing these integrated business solutions to merchants throughout the United States through three wholly-owned subsidiaries, eVance, Inc., Omnisoft.io, Inc., and CrowdPay.us, Inc.Financial HighlightsRevenues for the nine months ended...

Continue reading

Biometric Security Solutions Provider BIO-key Reports Q3 Results

WALL, N.J., Nov. 15, 2019 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric identity, authentication and security solutions, today reported results for its third quarter (Q3’19) ended September 30, 2019. BIO-key will host a conference call today at 10:00 a.m. ET (details below) to review its results and outlook.HighlightsGovernment & Election Security Progress: BIO-key Solutions Gain Traction with Capitol Lawmakers and Extend Penetration of Florida Election Security MarketChannel Alliance Partner Program: BIO-key Launched Channel Alliance Program to Support its Sales & Marketing Reach; Adds Technology Transfer Institute (TTI) of Africa to Expand Reach in High-Growth Market; Teams with Applied Technologies on Enterprise Authentication Solution for European CustomerLaw...

Continue reading

SANUWAVE Health Reports Third Quarter 2019 Financial Results

SUWANEE, Ga., Nov. 15, 2019 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2019 with the SEC on Thursday, November 14, 2019. The Company will also host a conference call today, November 15, 2019, at 9:00 a.m. Eastern Time. Highlights from the third quarter and last few weeks:Expect Q4 revenue to exceed $1million, due to the Brazil deal, Strong International orders, and domestic procedural revenue commencing.Placed 58 dermaPACE® Systems in the United States in total by the end of the third quarter and have achieved 70 placed by the end of October. On track to reach 85 by end of November and 110 by year end.  We plan to place at least 300 in 2020.Presented abstracts, symposium, and posters at four conferences in third quarter; DFCon, SAWC, AAWC Sacramento...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.